SCHEMBL1655707

SCHEMBL1655707

COc1ccc2[nH]c3c(c2c1)CCCN=C3

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.52
CYP1A2 P05177 3/20 0.52
CYP2D6 P10635 3/20 0.52
ALOX15 P16050 3/20 0.52
TDP1 Q9NUW8 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
RECQL P46063 2/20 0.52
HTR7 P34969 2/20 0.52
HTR2C P28335 2/20 0.52
CYP3A4 P08684 1/20 0.52
HTR2A P28223 1/20 0.52
CASP1 P29466 1/20 0.52
HTR6 P50406 1/20 0.52
MAPT P10636 4/20 0.50
SIRT1 Q96EB6 1/20 0.50
HSD17B10 Q99714 3/20 0.49
ALDH1A1 P00352 3/20 0.49
TSHR P16473 2/20 0.49
GFER P55789 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28631444 0.92 KDM4E (0.58) KDM4ECYP1A2CYP2D6ALOX15TDP1
SCHEMBL30921653 0.92 KDM4E (0.58) KDM4ECYP1A2CYP2D6ALOX15TDP1
Cgs-19281A SCHEMBL2930783 0.81 KDM4E (0.58) KDM4ECYP1A2CYP2D6ALOX15TDP1
Cgs-19281A SCHEMBL29769895 0.81 KDM4E (0.58) KDM4ECYP1A2CYP2D6ALOX15TDP1
SCHEMBL4279959 0.74 LMNA (0.67) KDM4ECYP1A2CYP2D6ALOX15TDP1
SCHEMBL4286367 0.74 LMNA (0.67) KDM4ECYP1A2CYP2D6ALOX15TDP1
SCHEMBL30477973 0.73 KDM4E (0.48) KDM4EMEN1KMT2AHTR2CMAPT
Calcium SCHEMBL29917796 0.73 LMNA (0.65) KDM4ECYP1A2CYP2D6ALOX15TDP1
SCHEMBL28172745 0.73 KDM4E (0.48) KDM4EMEN1KMT2AHTR2CMAPT
SCHEMBL2553660 0.71 PARP1 (0.69) KDM4ECYP1A2CYP2D6ALOX15TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041784-A1 METHODS FOR DIAGNOSING AND TREATING CANCER MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2011-04-07 WO disclosed
EP-1824498-A2 METHODS AND COMPOSITIONS FOR TREATING CELLULAR PROLIFERATIVE DISEASES THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2007-08-29 EP disclosed
WO-2006053315-A2 METHODS AND COMPOSITIONS FOR TREATING CELLULAR PROLIFERATIVE DISEASES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2006-05-18 WO disclosed